An in vivo BSL-2 model for henipavirus infection based on bioluminescence imaging of recombinant Cedar virus replication in mice
Frontiers in Chemical Biology · 2024
DOI: 10.3389/fchbi.2024.1363498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Chemical Biology, 2024. Verfasst von Celeste Huaman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Henipaviruses are enveloped single-stranded, negative-sense RNA viruses of the paramyxovirus family. Two henipaviruses, Nipah virus and Hendra virus, cause a systemic respiratory and/or neurological disease in humans and ten additional species of mammals, with a high fatality rate. Because of their highly pathogenic nature, Nipah virus and Hendra virus are categorized as BSL-4 pathogens, which limits the number and scope of translational research studies on these important human pathogens. To begin to address this limitation, we are developing a BSL-2 model of authentic henipavirus infection in mice, using the non-pathogenic henipavirus, Cedar virus. Notably, wild-type mice are highly resistant to Hendra virus and Nipah virus infection. However, previous work has shown that mice lacking expression of the type I interferon receptor (IFNAR-KO mice) are susceptible to both viruses. Here, we show that luciferase-expressing recombinant Cedar virus (rCedV-luc) is also able to replicate and establish a transient infection in IFNAR-KO mice, but not in wild-type mice. Using longitudinal bioluminescence imaging (BLI) of luciferase expression, we detected rCedV-luc replication as early as 10 h post-infection. Viral replication peaks between days 1 and 3 post-infection, and declines to levels undetectable by bioluminescence imaging by 7 days post-infection. Immunohistochemistry is consistent with viral infection and replication in endothelial cells and other non-immune cell types within tissue parenchyma. Serology analyses demonstrate significant IgG responses to the Cedar virus surface glycoprotein with potent neutralizing activity in IFNAR-KO mice, whereas antibody responses in wild-type animals were non-significant. Overall, these data suggest that rCedV-luc infection of IFNAR-KO mice represents a viable platform for the study of in vivo henipavirus replication, anti-henipavirus host responses and henipavirus-directed therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Rockville, MD, USA.
- Paul G. Allen School of Global Health, College of Veterinary Medicine, Washington State University, Pullman WA 99164 USA.
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Huaman, C., Clouse, C., Rader, M., Yan, L., Bai, S., Gunn, B. M., Amaya, M., Laing, E. D., Broder, C. C., & Schaefer, B. C. (2024). An in vivo BSL-2 model for henipavirus infection based on bioluminescence imaging of recombinant Cedar virus replication in mice. Frontiers in Chemical Biology. https://doi.org/10.3389/fchbi.2024.1363498
Vancouver
Huaman C, Clouse C, Rader M, Yan L, Bai S, Gunn BM, et al. An in vivo BSL-2 model for henipavirus infection based on bioluminescence imaging of recombinant Cedar virus replication in mice. Frontiers in Chemical Biology. 2024. doi:10.3389/fchbi.2024.1363498
BibTeX
@article{Huaman2024,
author = {Huaman, Celeste and Clouse, Caitlyn and Rader, Madeline and Yan, Lianying and Bai, Shuangyi and Gunn, Bronwyn M and Amaya, Moushimi and Laing, Eric D and Broder, Christopher C and Schaefer, Brian C},
title = {An in vivo BSL-2 model for henipavirus infection based on bioluminescence imaging of recombinant Cedar virus replication in mice},
journal = {Frontiers in Chemical Biology},
year = {2024},
doi = {10.3389/fchbi.2024.1363498}
}
EUVIMED